Modulation of the foreign body reaction for implants in the subcutaneous space: Microdialysis probes as localized drug delivery/sampling devices

Journal of Diabetes Science and Technology

Volumn 5, Issue 3, 2011, Pages 619-631

  Mou, Xiaodun ^a,d   Lennartz, Michelle R ^b   Loegering, Daniel J ^b   Stenken, Julie A ^c  

^a Research Rensselaer Polytechnic Institute   (United States)

^b ALBANY MEDICAL COLLEGE   (United States)

^c UNIVERSITY OF ARKANSAS   (United States)

^d PFIZER INC   (United States)

Author keywords

Calibration; Dexamethasone 21 phosphate; Foreign body reaction; Glucose; In vivo microdialysis sampling; MCP 1 CCL2

Indexed keywords

APOLATE SODIUM; CYANOCOBALAMIN; DEOXYGLUCOSE; DEXAMETHASONE SODIUM PHOSPHATE; GLUCOSE; MONOCYTE CHEMOTACTIC PROTEIN 1; PHENAZONE; DEXAMETHASONE; DEXAMETHASONE 21-PHOSPHATE; DRUG DERIVATIVE; XENOBIOTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; CMA 20 MICRODIALYSIS PROBE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG CAPSULE; DRUG DELIVERY DEVICE; DRUG DELIVERY SYSTEM; FLUID FLOW; FOREIGN BODY REACTION; GLUCOSE BLOOD LEVEL; MALE; MICRODIALYSIS; NONHUMAN; RAT; SUBCUTANEOUS TISSUE; ANIMAL; ARTICLE; BLOOD GLUCOSE MONITORING; CALIBRATION; INSTRUMENTATION; METHODOLOGY; SPRAGUE DAWLEY RAT; STATISTICAL MODEL;

ANIMALS; ANTIPYRINE; BLOOD GLUCOSE SELF-MONITORING; CALIBRATION; CHEMOKINE CCL2; DEOXYGLUCOSE; DEXAMETHASONE; DRUG DELIVERY SYSTEMS; FOREIGN-BODY REACTION; MALE; MICRODIALYSIS; MODELS, STATISTICAL; RATS; RATS, SPRAGUE-DAWLEY; VITAMIN B 12; XENOBIOTICS;

EID: 80051951389     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/193229681100500316     Document Type: Conference Paper

References (57)

1. Wilson GS, Johnson MA. In- vivo electrochemistry: what can we learn about living systems? Chem Rev. 2008;108(7):2462-81.
2. Garris PA. Advancing neurochemical monitoring. Nat Methods. 2010;7(2):106-8.
3. Fraser DM, editor. Biosensors in the body, Continuous in vivo monitoring. Chichester (UK): John Wiley & Sons; 1997.
4. Reach G, Choleau C. Continuous glucose monitoring: physiological and technological challenges. Curr Diabetes Rev. 2008;4(3):175-80.
5. Brauker J. Continuous glucose sensing: future technology developments. Diabetes Technol Ther. 2009;11(Suppl 1):S25-36.
6. Cunningham DD, Stenken JA, editors. In vivo glucose sensing. Hoboken (NJ): John Wiley & Sons, Inc.; 2010.
7. Wilson GS, Gifford R. Biosensors for real-time in vivo measurements. Biosens Bioelectron. 2005;20(12):2388-403. (Pubitemid 40602179)
8. Anderson JM, Rodriguez A, Chang DT. Foreign body reaction to biomaterials. Semin Immunol. 2008;20(2):86-100.
9. Wisniewski N, Moussy F, Reichert WM. Characterization of implantable biosensor membrane biofouling. Fresenius J Anal Chem. 2000;366(6-7):611-21.
10. Novak MT, Yuan F, Reichert WM. Modeling the relative impact of capsular tissue effects on implanted glucose sensor time lag and signal attenuation. Anal Bioanal Chem. 2010;398(4):1695-705.
11. Hoss U, Jeddi I, Schulz M, Budiman E, Bhogal C, McGarraugh G. Continuous glucose monitoring in subcutaneous tissue using factory-calibrated sensors: a pilot study. Diabetes Technol Ther. 2010;12(8):591-7.
12. Gant RM, Hou Y, Grunlan MA, Cote GL. Development of a selfcleaning sensor membrane for implantable biosensors. J Biomed Mater Res A. 2009;90(3):695-701.
13. Ward WK. A review of the foreign-body response to subcutaneously- implanted devices: The role of macrophages and cytokines in biofouling and fibrosis. J Diabetes Sci Technol. 2008;2(5):768-77.
14. Yu B, Ju Y, West L, Moussy Y, Moussy F. An investigation of longterm performance of minimally invasive glucose biosensors. Diabetes Technol Ther. 2007;9(3):265-75. (Pubitemid 46959792)
15. Hetrick EM, Schoenfisch MH. Reducing implant-related infections: active release strategies. Chem Soc Rev. 2006;35(9):780-9. (Pubitemid 44286273)
16. Nandi P, Lunte SM. Recent trends in microdialysis sampling integrated with conventional and microanalytical systems for monitoring biological events: a review. Anal Chim Acta. 2009;651(1):1-14.
17. Westerink BHC, Cremers TIFH, editors. Handbook of microdialysis sampling: methods, applications, and clinical aspects. Amsterdam: Academic Press; 2007.
18. Bungay PM, Morrison PF, Dedrick RL. Steady-state theory for quantitative microdialysis of solutes and water in vivo and in vitro. Life Sci. 1990;46(2):105-19. (Pubitemid 20034442)
19. Bungay PM, Newton-Vinson P, Isele W, Garris PA, Justice JB. Microdialysis of dopamine interpreted with quantitative model incorporating probe implantation trauma. J Neurochem. 2003;86(4):932-46. (Pubitemid 36988805)
20. Stenken JA. Methods and issues in microdialysis calibration. Anal Chim Acta. 1999;379:337-58. (Pubitemid 29046463)
21. Henninger N, Woderer S, Kloetzer H-M, Staib A, Gillen R, Li L, Yu X, Gretz N, Kraenzlin B, Pill J. Tissue response to subcutaneous implantation of glucose-oxidase-based glucose sensors in rats. Biosens Bioelectron. 2007;23(1):26-34. (Pubitemid 47375081)
22. Ju YM, Yu B, West L, Moussy Y, Moussy F. A novel porous collagen scaffold around an implantable biosensor for improving biocompatibility. II. Long-term in vitro/in vivo sensitivity characteristics of sensors with NDGA- or GA-crosslinked collagen scaffolds. J Biomed Mater Res A. 2010;92(2):650-8.
23. Wisniewski N, Rajamand N, Adamsson U, Lins PE, Reichert WM, Klitzman B, Ungerstedt U. Analyte flux through chronically implanted subcutaneous polyamide membranes differs in humans and rats. Am J Physiol. 2002;282(6):E1316-23. (Pubitemid 34654701)
24. Norton LW, Koschwanez HE, Wisniewski NA, Klitzman B, Reichert WM. Vascular endothelial growth factor and dexamethasone release from nonfouling sensor coatings affect the foreign body response. J Biomed Mater Res A. 2007;81(4):858-69. (Pubitemid 46835081)
25. Bridges AW, Whitmire RE, Singh N, Templeman KL, Babensee JE, Lyon LA, Garcia AJ. Chronic inflammatory responses to microgelbased implant coatings. J Biomed Mater Res A. 2010;94(1):252-8.
26. Rodriguez A, Meyerson H, Anderson JM. Quantitative in vivo cytokine analysis at synthetic biomaterial implant sites. J Biomed Mater Res A. 2009;89(1):152-9.
27. Mou X, Lennartz MR, Loegering DJ, Stenken JA. Long-term calibration considerations during subcutaneous microdialysis sampling in mobile rats. Biomaterials. 2010;31(16):4530-9.
28. Deshmane SL, Kremlev S, Amini S, Sawaya BE. Monocyte chemo-attractant protein-1 (MCP-1): an overview. J Interferon Cytokine Res. 2009;29(6):313-26.
29. Derendorf H, Rohdewald P, Hochhaus G, Möllmann H. HPLC determination of glucocorticoid alcohols, their phosphates and hydrocortisone in aqueous solutions and biological fluids. J Pharm Biomed Anal. 1986;4(2):197-206. (Pubitemid 16024580)
30. Morais JM, Papadimitrakopoulos F, Burgess DJ. Biomaterials/tissue interactions: possible solutions to overcome foreign body response. AAPS J. 2010;12(2):188-96.
31. Ward WK, Hansen JC, Massoud RG, Engle JM, Takeno MM, Hauch KD. Controlled release of dexamethasone from subcutaneously-implanted biosensors in pigs: localized anti-inflammatory benefit without systemic effects. J Biomed Mater Res A. 2010;94(1):280-7.
32. Hazel JR, Sidell BD. A method for the determination of diffusion coefficients for small molecules in aqueous solution. Anal Biochem. 1987;166(2):335-41.
33. Snyder KL, Nathan CE, Yee A, Stenken JA. Diffusion and calibration properties of microdialysis sampling membranes in biological media. Analyst. 2001;126(8):1261-8. (Pubitemid 32747741)
34. Moussy Y, Dungel P, Hersh L. Diffusion of [3H]dexamethasone in rat subcutaneous slices after injection measured by digital autoradiography. Biotechnol Prog. 2006;22(6):1715-9. (Pubitemid 44912678)
35. Renkin EM. Filtration, diffusion, and molecular sieving through porous cellulose membranes. J Gen Physiol. 1954;38(2):225-43.
36. Altieri AS, Hinton DP, Byrd RA. Association of biomolecular systems via pulsed field gradient NMR self-diffusion measurements. J Am Chem Soc. 1995;117(28):7566-7.
37. Paavola CD, Hemmerich S, Grunberger D, Polsky I, Bloom A, Freedman R, Mulkins M, Bhakta S, McCarley D, Wiesent L, Wong B, Jarnagin K, Handel TM. Monomeric monocyte chemoattractant protein-1 (MCP-1) binds and activates the MCP-1 receptor CCR2B. J Biol Chem. 1998;273(50):33157-65. (Pubitemid 29005686)
38. Kanamori T, Sakai K, Awaka T, Fukuda M. An improvement on the method of determining the solute permeability of hollowfiber dialysis membranes photometrically using optical fibers and comparison of the method with ordinary techniques. J Membr Sci. 1994;88(2-3):159-65.
39. Mou X. Modulation of foreign body response towards implanted microdialysis probes [Ph.D. dissertation]. Troy (NY): Rensselaer Polytechnic Institute; 2007.
40. Hickey T, Kreutzer D, Burgess DJ, Moussy F. Dexamethasone/ PLGA microspheres for continuous delivery of an anti-inflammatory drug for implantable medical devices. Biomaterials. 2002;23(7):1649-56. (Pubitemid 34158587)
41. Bancroft J, Gamble M. Theory and practice of histological techniques. London (England): Churchill Livingstone; 2001.
42. Lugo RA, Nahata MC. Stability of diluted dexamethasone sodium phosphate injection at two temperatures. Ann Pharmacother. 1994;28(9):1018-9. (Pubitemid 24292687)
43. Woodward SC. How fibroblasts and giant cells encapsulate implants: considerations in design of glucose sensors. Diabetes Care. 1982;5(3):278-81. (Pubitemid 12117181)
44. Schoonen AJ, Wientjes KJ. A model for transport of glucose in adipose tissue to a microdialysis probe. Diabetes Technol Ther. 2003;5(4):589-98. (Pubitemid 36999271)
45. Sharkawy AA, Klitzman B, Truskey GA, Reichert WM. Engineering the tissue which encapsulates subcutaneous implants. III. Effective tissue response times. J Biomed Mater Res. 1998;40(4):598-605. (Pubitemid 28225845)
46. Thennadil SN, Rennert JL, Wenzel BJ, Hazen KH, Ruchti TL, Block MB. Comparison of glucose concentration in interstitial fluid, and capillary and venous blood during rapid changes in blood glucose levels. Diabetes Technol Ther. 2001;3(3):357-65. (Pubitemid 33032545)
47. Wisniewski N, Klitzman B, Miller B, Reichert WM. Decreased analyte transport through implanted membranes: differentiation of biofouling from tissue effects. J Biomed Mater Res. 2001;57(4):513-21. (Pubitemid 32937532)
48. Conti P, Feliciani C, Barbacane RC, Frydas S, Placido FC, Cataldo I, Reale M. Monocyte chemotactic protein-1 gene expression and translation in formed granulomatous calcified tissue in vivo. Calcif Tissue Int. 1999;64(1):57-62. (Pubitemid 29024630)
49. Clark H, Barbari TA, Stump K, Rao G. Histologic evaluation of the inflammatory response around implanted hollow fiber membranes. J Biomed Mater Res. 2000;52(1):183-192. (Pubitemid 30490996)
50. Wientjes KJ, Vonk P, Vonk-van Klei Y, Schoonen AJ, Kossen NW. Microdialysis of glucose in subcutaneous adipose tissue up to 3 weeks in healthy volunteers. Diabetes Care. 1998;21(9):1481-8. (Pubitemid 28405200)
51. Labow RS, Sa D, Matheson LA, Santerre JP. Polycarbonate-urethane hard segment type influences esterase substrate specificity for human-macrophage- mediated biodegradation. J Biomater Sci Polym Ed. 2005;16(9):1167-77. (Pubitemid 44056351)
52. Ito T, Fraser IP, Yeo Y, Highley CB, Bellas E, Kohane DS. Antiinflammatory function of an in situ cross-linkable conjugate hydrogel of hyaluronic acid and dexamethasone. Biomaterials. 2007;28(10):1778-86. (Pubitemid 46137996)
53. Thieme TR, Mirkovich A, Maloney P, Goodwin DA. In vivo and in vitro effects of dexamethasone on leukocyte migration in the rat adjuvant arthritis model. Inflammation. 1982;6(4):371-86. (Pubitemid 13191699)
54. Auerbach W, Auerbach R. Angiogenesis inhibition: a review. Pharmacol Ther. 1994;63(3):265-311. (Pubitemid 24315751)
55. Nauck M, Karakiulakis G, Perruchoud AP, Papakonstantinou E, Roth M. Corticosteroids inhibit the expression of the vascular endothelial growth factor gene in human vascular smooth muscle cells. Eur J Pharmacol. 1998;341(2-3):309-15. (Pubitemid 28131129)
56. Edelman JL, Lutz D, Castro MR. Corticosteroids inhibit VEGFinduced vascular leakage in a rabbit model of blood-retinal and blood-aqueous barrier breakdown. Exp Eye Res. 2005;80(2):249-58.
57. Rajamand Ekberg N, Brismar K, Malmstedt J, Hedblad M-A, Adamson U, Ungerstedt U, Wisniewski N. Analyte flux at a biomaterial-tissue interface over time: implications for sensors for type 1 and 2 diabetes mellitus. J Diabetes Sci Technol. 2010;4(5):1063-72.